Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts
Use of 2-octylcyanoacrylate (Dermabond) During Cutaneous Wound Closure With Full-thickness Skin Grafts: a Randomized Split Wound Comparative Effectiveness Trial
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of cutaneous surgery wounds with full-thickness skin grafts improves scar cosmesis compared to wound closure with sutures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 9, 2015
CompletedFirst Posted
Study publicly available on registry
September 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedJune 21, 2017
December 1, 2016
1.3 years
September 9, 2015
June 19, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Appearance of Scar on the Patient and Observer Scar Assessment Scale
After surgical procedure, half of the subject's wound will be with 2-octylcyanoacrylate, while the other half is closed 5-0 vicryl sutures. After 3 months, subjects will return to clinic for evaluation of the cosmesis of both types of closure techniques.
3 months
Secondary Outcomes (2)
Incidence of Graft Failure on Case Report
3 months
Incidence of Complications on Case Report
3 months
Study Arms (2)
Wound closure with 2-octylcyanoacrylate
EXPERIMENTALOne side of the patient's wound defect will be assigned to wound closure with 2-octylcyanoacrylate liquid bonding agent).
Wound closure with 5-0 vicryl sutures
ACTIVE COMPARATOROne side of the patient's wound defect will be assigned to wound closure with 5-0 vicryl sutures.
Interventions
Eligibility Criteria
You may qualify if:
- Over 18 years of age
- Able to give informed consent themselves
- Patient scheduled for cutaneous surgical procedure with predicted closure with full-thickness skin graft
- Willing to return for follow-up visits
You may not qualify if:
- Mentally handicapped
- Unable to understand written and oral English
- Incarceration
- Under 18 years of age
- Pregnant Women
- Patients on systemic steroid therapies
- Patients with Marfans
- Patients with allergies to 2-octylcyanoacrylate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Eisen, M.D.
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2015
First Posted
September 15, 2015
Study Start
August 1, 2015
Primary Completion
December 1, 2016
Study Completion
May 1, 2017
Last Updated
June 21, 2017
Record last verified: 2016-12